Top Markets
#1 Zora Zora +34.58%
#2 AI XOVIA AI XOVIA +31.92%
#3 Full Moon Full Moon +18.72%
#4 Notcoin Notcoin +18.03%
#5 0G 0G +14.89%
#6 Axelar Axelar +13.12%
#7 rsERG rsERG +12.40%
#8 Wrapped NXM Wrapped NXM +12.21%
#9 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +10.46%
#10 Yield Basis Yield Basis +9.87%
Coin of the day
Zora Zora
सेटिंग्स
भाषा
हिन्दी
मुद्रा
USD
थीम
Eikon Therapeutics, Inc. Common Stock Eikon Therapeutics, Inc. Common Stock

Eikon Therapeutics, Inc. Common Stock

EIKN
शेयरों में रैंक #12325
Eikon Therapeutics, Inc. is a clinical biopharmaceutical company, established... Eikon Therapeutics, Inc. is a clinical biopharmaceutical company, established in 2019 and headquartered in Millbrae, California, operating within the United States. The company is dedicated to developing groundbreaking medicines to address significant unmet medical needs. It utilizes a proprietary platform capable of precisely characterizing protein interactions inside living cells. Eikon's drug pipeline includes EIK1001, a systemically delivered TLR 7/8 dual-agonist designed to activate both innate and adaptive anti-cancer immune responses; EIK1003 and EIK1004, which are selective PARP1 inhibitors for ovarian, breast, prostate, and pancreatic cancers. Notably, EIK1004 is brain-penetrant, offering a therapeutic approach for brain metastases and primary brain malignancies. Additionally, EIK1005 is a potent WRN helicase inhibitor and anti-tumor agent aimed at MSI-high tumors, alongside EIK1006.
शेयर मूल्य
$11.03
अंतिम समन्वयन: 2026-08-28
मार्केट कैप
$597.15M
बदलाव (1 दिन)
-4.25%
बदलाव (1 वर्ष)
-
देश
US
व्यापार Eikon Therapeutics, Inc. Common Stock (EIKN)

श्रेणी

Healthcare
Eikon Therapeutics, Inc. Common Stock (EIKN) के लिए P/B अनुपात
2026 को P/B अनुपात TTM: 0
Eikon Therapeutics, Inc. Common Stock की नवीनतम वित्तीय रिपोर्ट और शेयर मूल्य के अनुसार, कंपनी का वर्तमान P/B अनुपात (TTM) 0 है। 2026 के अंत में, कंपनी का P/B अनुपात 0 था।
Eikon Therapeutics, Inc. Common Stock के लिए 2026 से 2026 तक P/B अनुपात का इतिहास
हर वर्ष के अंत में P/B अनुपात
वर्ष P/B अनुपात परिवर्तन
प्रदान की गई तारीखों के लिए पर्याप्त डेटा नहीं।
समान कंपनियों या प्रतिस्पर्धियों के लिए P/B अनुपात
कंपनी P/B अनुपात P/B अनुपात में अंतर देश
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 2.5054 -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 3.7087 -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH